The management of ulcerative colitis and granulomatous colitis.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003092:Colitis / Q000150:complications / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D003348:Cortisone / Q000627:therapeutic use; D005260:Female; D005401:Fissure in Ano / Q000150:complications; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D012871:Skin Diseases / Q000150:complications; D012460:Sulfasalazine / Q000627:therapeutic use; D013923:Thromboembolism / Q000150:complications; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D005765:Gastrointestinal Agents; D014149:Tranquilizing Agents; D012460:Sulfasalazine; D000324:Adrenocorticotropic Hormone; D003348:Cortisone; D011241:Prednisone; D006854:Hydrocortisone